loader from loading.io

ANA Investigates Updates in Autoimmune Encephalitis, part 2, therapeutics

ANA Investigates

Release Date: 07/26/2022

ANA Investigates Teleneurology and Healthcare Equity show art ANA Investigates Teleneurology and Healthcare Equity

ANA Investigates

Equitable tele-neurologic care starts with first identifying disparities, then identifying how to overcome them – learn about both with Dr. Lee Schwamm on the latest ANA Investigates. Series 3, Episode 11. Featuring: Guest: Dr. Lee Schwamm, C Miller Fisher Endowed Chair in Vascular Neurology and the Director of the Center for TeleHealth at Massachusetts General Hospital, Professor of Neurology at Harvard Medical School and Vice President for Digital Patient Experience at the Mass General Brigham Health System. Interviewer/Producer: Amanda Jagolino-Cole, Director of the UT Teleneurology...

info_outline
*Special Episode* ANA Investigates Potential Fabrication in AD Research Images show art *Special Episode* ANA Investigates Potential Fabrication in AD Research Images

ANA Investigates

Late last month, the journal Science published an investigative report that accused a much-cited publication in Alzheimer’s disease... of fabricating scientific images. The study under scrutiny was published in Nature in 2006 by Sylvain Lesné and colleagues. It claimed that an amyloid oligomer called Aβ*56 impaired memory in mice. The recent Science report found potential fabrication in the images used in that paper... and concluded that this potential fabrication threatens the amyloid hypothesis in Alzheimer’s disease. Here at ANA Investigates, we decided we needed to ask the experts...

info_outline
ANA Investigates Updates in Autoimmune Encephalitis, part 2, therapeutics show art ANA Investigates Updates in Autoimmune Encephalitis, part 2, therapeutics

ANA Investigates

Last month on the podcast, we talked about updates in the diagnosis of autoimmune encephalitis. This month we turn to advances in the treatment of autoimmune encephalitis. Treating these conditions has traditionally been practitioner-dependent, and currently no FDA-approved therapies exist. But that’s beginning to change. Series 3, Episode 9. Featuring: Guest: Dr. Maarten Titulaer, Erasmus MC University Medical Center Interviewer/Producer: Dr. Rohini Samudralwar, University of Pennsylvania Disclosures: Dr. Titulaer disclosed that his institution receives consulting funds form UCB, Viela...

info_outline
ANA Investigates Updates in Autoimmune Encephalitis, part 1, diagnostics show art ANA Investigates Updates in Autoimmune Encephalitis, part 1, diagnostics

ANA Investigates

On today's episode, Dr. Adeline Goss interviews Dr. Andrew McKeon on updates on diagnostics for part one of a two-part series on autoimmune encephalitis. Series 3, Episode 8. Featuring: Guest: Andrew McKeon, M.B., B.Ch., M.D., Mayo Clinic College of Medicine and Science Interviewer/Producer: Adeline Goss, MD, Highland Hospital Disclosures: Dr. McKeon disclosed that he is a consultant for Johnson & Roche Genentech; and receives royalties from Euroimmun

info_outline
ANA Investigates TIA show art ANA Investigates TIA

ANA Investigates

On today's episode, we discuss the term "TIA" and the current debate as it pertains to advances in stroke diagnostics that have led some to propose that we retire the term. Series 3, Episode 7. Featuring: Guest: Clay Johnston, MD, PhD, The University of Texas at Austin Interviewer/Producer: Megan Richie, MD, UCSF Disclosures: Dr. Johnston disclosed research support from AstraZeneca for the THALES trial.

info_outline
ANA Investigates Neurobiology of Burnout show art ANA Investigates Neurobiology of Burnout

ANA Investigates

Burnt out by talking about burnout? Please join us for a podcast with Dr. Amy Arnsten, Professor of Neuroscience and Psychology at Yale University, to investigate what goes on in the brain that leads to burnout and how this can direct our efforts to reduce burnout. Series 3, Episode 6. Featuring: Guest: Dr. Amy Arnsten, Professor of Neuroscience and Psychology at Yale University - Interviewer/Producer: Dr. Amanda Jagolino-Cole of the McGovern Medical at the University of Texas Health Science Center in Houston Disclosures: None Dr. Arnsten provided additional resources, and these may be...

info_outline
ANA Investigates Biomarkers for Alzheimer's Disease show art ANA Investigates Biomarkers for Alzheimer's Disease

ANA Investigates

On today’s show, we’ll focus on the future of biomarkers in Alzheimer’s disease. We know that amyloid beta and tau protein deposit long before patients with Alzheimer’s develop symptoms. If we could use biomarkers to detect this pathology early, and treat patients early, could we prevent the progression to dementia? Our guests today are leaders in the development of biomarkers for Alzheimer’s disease - Dr. Suzanne Schindler, Associate Professor of Neurology at Washington University in St. Louis and Dr. Gil Rabinovici, Professor of Neurology and Radiology at the University of...

info_outline
ANA Investigates Curing Coma show art ANA Investigates Curing Coma

ANA Investigates

Can coma be “cured”? On this podcast, we talk to Dr. Claude Hemphill and Dr. Romer Geocadin of the Curing Coma Campaign. Series 3, Episode 4 Featuring: Guests: Romer Geocadin, MD, Johns Hopkins University & Claude Hemphill, MD, University of California San Francisco Interviewer/Producer: Dr. Adeline Goss Disclosures: None Below are articles the guests of this podcast wished to share with the listeners: Early Thalamocortical Reperfusion Leads to Neurologic Recovery in a Rodent Cardiac Arrest Model: https://doi.org/10.1007/s12028-021-01432-9 Proceedings of the First Curing...

info_outline
ANA Investigates Basilar Artery Stroke show art ANA Investigates Basilar Artery Stroke

ANA Investigates

Treatment of stroke has changed dramatically in the past decade, with the advent of perfusion imaging and an expanded time window for mechanical thrombectomy. Thrombectomy is now standard of care for eligible patients. But while data clearly supports the use of thrombectomy for certain patients with anterior circulation strokes, the benefit of thrombectomy for patients with basilar artery occlusions remains unproven. Today we’ll talk to a vascular neurologist and a neurointerventional surgeon who are trying to better define which patients with basilar artery occlusion may benefit from...

info_outline
ANA Investigates FND show art ANA Investigates FND

ANA Investigates

On today’s show we’ll focus on functional neurological disorder, or FND -- a wide range of conditions including non-epileptic seizures and functional weakness, dystonia and tremor. These conditions are common and can cause serious disability. But what are these conditions, exactly? What have functional neuroimaging and other tools taught us about their pathophysiology, diagnosis, and treatment? Series 3, Episode 2 Featuring: - Guest: Dr. Sara Finkelstein, neurologist and specialist in functional neurological disorder at Massachusetts General Hospital - Interviewer/Producer: Dr. Adeline...

info_outline
 
More Episodes

Last month on the podcast, we talked about updates in the diagnosis of autoimmune encephalitis. This month we turn to advances in the treatment of autoimmune encephalitis. Treating these conditions has traditionally been practitioner-dependent, and currently no FDA-approved therapies exist. But that’s beginning to change. Series 3, Episode 9. Featuring:

  • Guest: Dr. Maarten Titulaer, Erasmus MC University Medical Center
  • Interviewer/Producer: Dr. Rohini Samudralwar, University of Pennsylvania
  • Disclosures: Dr. Titulaer disclosed that his institution receives consulting funds form UCB, Viela Bio (Horizon), and CSL Behring, he is the co-investigator on the ExTinguish trial funded in part by Horizon, and a PI IVIG trial funded by CSL Behring.